Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Normobaric Oxygen in Acute Migraine
NCT01542307Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Jul 2012
- Primary completion
- Sep 2015
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of oxygen in migraine (2 arms), sponsored by Massachusetts General Hospital. Primary endpoint: Change in Pain Scores From 0-30 Minutes on a Visual Analog Scale (VAS) at 30 months. Started Jul 2012; status: completed.
02
Drugs
oxygen
03
Conditions
migraine
Beyond the preview
Go deeper on NCT01542307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01542307.